Ameriprise’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.96B | Buy |
16,262,708
+288,299
| +2% | +$33.3M | 0.45% | 32 |
|
|
2025
Q4 | $1.68B | Buy |
15,974,409
+40,500
| +0.3% | +$3.8M | 0.38% | 40 |
|
|
2025
Q3 | $1.34B | Buy |
15,933,909
+2,735,459
| +21% | +$225M | 0.31% | 60 |
|
|
2025
Q2 | $1.04B | Buy |
13,198,450
+299,561
| +2% | +$23.8M | 0.26% | 76 |
|
|
2025
Q1 | $1.16B | Sell |
12,898,889
-1,065,775
| -8% | -$99.5M | 0.31% | 63 |
|
|
2024
Q4 | $1.39B | Sell |
13,964,664
-3,200,521
| -19% | -$330M | 0.36% | 48 |
|
|
2024
Q3 | $1.95B | Buy |
17,165,185
+540,100
| +3% | +$64.2M | 0.5% | 29 |
|
|
2024
Q2 | $2.06B | Sell |
16,625,085
-346,147
| -2% | -$44.6M | 0.56% | 24 |
|
|
2024
Q1 | $2.24B | Buy |
16,971,232
+557,932
| +3% | +$68.8M | 0.62% | 19 |
|
|
2023
Q4 | $1.79B | Sell |
16,413,300
-188,332
| -1% | -$19.5M | 0.54% | 31 |
|
|
2023
Q3 | $1.71B | Sell |
16,601,632
-429,593
| -3% | -$46.3M | 0.56% | 26 |
|
|
2023
Q2 | $1.97B | Sell |
17,031,225
-293,372
| -2% | -$33.3M | 0.62% | 22 |
|
|
2023
Q1 | $1.84B | Sell |
17,324,597
-1,613,717
| -9% | -$174M | 0.6% | 22 |
|
|
2022
Q4 | $2.1B | Sell |
18,938,314
-218,769
| -1% | -$22.4M | 0.72% | 17 |
|
|
2022
Q3 | $1.65B | Buy |
19,157,083
+1,387,491
| +8% | +$124M | 0.61% | 24 |
|
|
2022
Q2 | $1.62B | Buy |
17,769,592
+1,092,307
| +7% | +$96.8M | 0.56% | 29 |
|
|
2022
Q1 | $1.36B | Buy |
16,677,285
+876,457
| +6% | +$69.1M | 0.4% | 45 |
|
|
2021
Q4 | $1.2B | Buy |
15,800,828
+2,892,046
| +22% | +$230M | 0.33% | 55 |
|
|
2021
Q3 | $970M | Sell |
12,908,782
-488,272
| -4% | -$37.1M | 0.31% | 60 |
|
|
2021
Q2 | $1.04B | Sell |
13,397,054
-3,691,316
| -22% | -$275M | 0.32% | 55 |
|
|
2021
Q1 | $1.26B | Sell |
17,088,370
-1,140,707
| -6% | -$84.1M | 0.42% | 44 |
|
|
2020
Q4 | $1.42B | Sell |
18,229,077
-1,479,301
| -8% | -$113M | 0.5% | 32 |
|
|
2020
Q3 | $1.56B | Sell |
19,708,378
-3,439,452
| -15% | -$269M | 0.63% | 22 |
|
|
2020
Q2 | $1.71B | Buy |
23,147,830
+214,862
| +0.9% | +$16.2M | 0.73% | 17 |
|
|
2020
Q1 | $1.68B | Buy |
22,932,968
+3,924,461
| +21% | +$308M | 0.88% | 12 |
|
|
2019
Q4 | $1.65B | Buy |
19,008,507
+444,336
| +2% | +$36.5M | 0.69% | 22 |
|
|
2019
Q3 | $1.49B | Buy |
18,564,171
+1,905,400
| +11% | +$153M | 0.67% | 24 |
|
|
2019
Q2 | $1.33B | Buy |
16,658,771
+211,421
| +1% | +$16.2M | 0.6% | 23 |
|
|
2019
Q1 | $1.31B | Buy |
16,447,350
+3,476,384
| +27% | +$260M | 0.6% | 28 |
|
|
2018
Q4 | $946M | Buy |
12,970,966
+244,026
| +2% | +$17.2M | 0.47% | 34 |
|
|
2018
Q3 | $1.01B | Buy |
12,726,940
+264,708
| +2% | +$16.9M | 0.35% | 55 |
|
|
2018
Q2 | $722M | Sell |
12,462,232
-3,549,075
| -22% | -$200M | 0.32% | 60 |
|
|
2018
Q1 | $833M | Sell |
16,011,307
-7,097,806
| -31% | -$383M | 0.38% | 50 |
|
|
2017
Q4 | $1.24B | Sell |
23,109,113
-1,535,526
| -6% | -$85.1M | 0.57% | 31 |
|
|
2017
Q3 | $1.51B | Buy |
24,644,639
+1,709,302
| +7% | +$104M | 0.72% | 25 |
|
|
2017
Q2 | $1.4B | Buy |
22,935,337
+26,519
| +0.1% | +$1.61M | 0.7% | 23 |
|
|
2017
Q1 | $1.39B | Sell |
22,908,818
-594,566
| -3% | -$36.1M | 0.72% | 21 |
|
|
2016
Q4 | $1.32B | Sell |
23,503,384
-336,220
| -1% | -$19.7M | 0.72% | 22 |
|
|
2016
Q3 | $1.42B | Sell |
23,839,604
-256,685
| -1% | -$15M | 0.8% | 16 |
|
|
2016
Q2 | $1.32B | Buy |
24,096,289
+4,682,976
| +24% | +$249M | 0.78% | 19 |
|
|
2016
Q1 | $980M | Buy |
19,413,313
+2,590,682
| +15% | +$127M | 0.58% | 31 |
|
|
2015
Q4 | $848M | Sell |
16,822,631
-2,756,587
| -14% | -$139M | 0.5% | 37 |
|
|
2015
Q3 | $923M | Sell |
19,579,218
-965,636
| -5% | -$51.3M | 0.57% | 32 |
|
|
2015
Q2 | $1.12B | Sell |
20,544,854
-3,489,598
| -15% | -$196M | 0.64% | 24 |
|
|
2015
Q1 | $1.32B | Sell |
24,034,452
-1,686,407
| -7% | -$95.5M | 0.76% | 17 |
|
|
2014
Q4 | $1.39B | Buy |
25,720,859
+523,779
| +2% | +$29.2M | 0.81% | 13 |
|
|
2014
Q3 | $1.43B | Buy |
25,197,080
+2,832,890
| +13% | +$159M | 0.86% | 11 |
|
|
2014
Q2 | $1.23B | Buy |
22,364,190
+2,154,029
| +11% | +$118M | 0.73% | 16 |
|
|
2014
Q1 | $1.09B | Buy |
20,210,161
+1,714,003
| +9% | +$88.8M | 0.66% | 17 |
|
|
2013
Q4 | $884M | Buy |
18,496,158
+2,984,442
| +19% | +$136M | 0.54% | 26 |
|
|
2013
Q3 | $705M | Sell |
15,511,716
-3,337,378
| -18% | -$152M | 0.46% | 36 |
|
|
2013
Q2 | $836M | Buy |
+18,849,094
| New | +$842M | 0.58% | 22 |
|
Other funds holding MRK
VCM
VPM
Ameriprise's MRK Position: Q1 2026 in Review
Ameriprise increased its Merck (MRK) stake by 1.8% in Q1 2026, buying an estimated $33.3M and bringing the position to 16,262,708 shares worth $1.96B. The position accounts for 0.45% of the portfolio, ranked #32.
Ameriprise first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.24B in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Ameriprise held 16,262,708 shares of Merck worth $1.96B as of Q1 2026.
- Ameriprise bought 288,299 Merck shares in Q1 2026, an estimated $33.3M.
- Merck made up 0.45% of Ameriprise's portfolio in Q1 2026, its #32 holding.
- Ameriprise first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Merck position peaked at $2.24B in Q1 2024.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.